| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $275.1K | $99.8K | $35.2K |
| YoY Revenue Growth % | +175.7% | +183.4% | — |
| Gross Profit | — | $99.8K | — |
| Gross Margin % | — | 98.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$12.6M | -$36.5M | -$11.7M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$8.6M | -$33.7M | -$11.7M |
| EBITDA (Normalized) | -$12.6M | -$36.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.1M | -$14.0M | -$5.1M |
| Capital Expenditures (CapEx) | $23.5K | $53.0K | — |
| Free Cash Flow (FCF) | -$5.1M | -$14.1M | -$5.1M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $172.1K | $149.3K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $3.5M | $2.6M | — |